Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Comiskey
Brian Comiskey, Colo De Caza, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110048033 | CLIMATE CONTROL SYSTEMS AND METHODS - A method for thermally conditioning a space adjacent a seat assembly includes activating a heating element positioned within the seat assembly beneath a seat covering. A fluid module that includes a fluid supply device and a thermoelectric element is activated to direct heated air from the fluid module to a space adjacent the seat assembly through a distribution system formed at least partially in the seat cushion. After a period of time, the heating element is deactivated. | 03-03-2011 |
Brian D. Comiskey, Coto De Caza, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110031272 | CHEMICAL DISPENSING SYSTEMS AND POSITIVE DISPLACEMENT FLOW METERS THEREFOR - A volume-based, rather than time-based, system for dispensing fluid incorporates a microprocessor-based controller, software, pump, and positive displacement flow meter. The volume being pumped and the time it takes to pump that volume is calculated and tracked by the software, giving a flow rate. This rate is then tracked by the software for any changes. Any conditional changes that occur, affecting this rate, are tracked, and if the rate becomes too excessive outside of the normal rate established at initial calibration, then an alarm or other indication is provided to the operator. | 02-10-2011 |
| 20110119826 | OPERATIONAL SCHEMES FOR CLIMATE CONTROLLED BEDS - A climate controlled seat, bed or other assembly configured to receive a person includes a blower and two or more thermoelectric devices or other conditioning fluid modules. According to one embodiment of an operational scheme, a control system for the seat or bed is configured to continuously discharge air from the blower through the thermoelectric devices. In one arrangement, the thermoelectric devices are sequenced between an activated and a deactivated position. Consequently, the desired cooling and/or cooling effect can be maintained while reducing energy consumption of the climate control system. | 05-26-2011 |
John Comiskey, Carlsbad, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100317064 | Covalent joining of DNA strands to RNA strands catalyzed by vaccinia topoisomerase - The present invention provides a method of covalently joining a DNA strand to an RNA strand comprising (a) forming a topoisomerase-DNA intermediate by incubating a DNA cleavage substrate comprising a topoisomerase cleavage site with a topoisomerase specific for that site, wherein the topoisomerase-DNA intermediate has one or more 5′ single-strand tails; and (b) adding to the topoisomerase-DNA intermediate an acceptor RNA strand complementary to the 5′ single-strand tail under conditions permitting a ligation of the covalently bound DNA strand of the topoisomerase-DNA intermediate to the RNA acceptor strand and dissociation of the topoisomerase, thereby covalently joining the DNA strand to the RNA strand. The present invention also provides a method of tagging a 5′ end of an RNA molecule. The present invention further provides a DNA-RNA molecule which has been joined in vitro by the use of a topoisomerase. The present invention also provides a method of tagging a 5′ end of an mRNA. The present invention provides a method of isolating and cloning full-length gene sequences using capped mRNA after subtraction of non-capped RNA. | 12-16-2010 |
Peter Comiskey, Hertfordshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20110061930 | JUNCTION BOX - A junction box, comprising a multi-layer circuit board, wherein the circuit board ( | 03-17-2011 |
Stephen Comiskey, Doylestown, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100221329 | FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE - The invention provides novel formulations of guanylate cyclase-C (“GCC”) agonist peptides and methods for their use in the treatment of gastrointestinal diseases and disorders, including gastrointestinal cancer. The GCC agonist formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative. | 09-02-2010 |